A Comprehensive Review of Metastatic Colorectal Cancer (mCRC) Management: An Interprofessional Approach to Care

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by American Academy of CME, Inc.

This activity is supported in part by an independent education grant from Merck.

Credit Available

• Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)™
• Nurses — 1.5 Contact Hours
• Pharmacists — 1.50 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of oncologists, oncology nurses and pharmacists engaged in the care of patients with metastatic colorectal cancer.

Program Overview

This activity will address changes in treatment combinations and sequencing of regimens, as well as molecular markers that should be tested to guide therapy. Further, supportive care measures and continual monitoring based on their therapy to ensure optimal outcomes and minimize adverse effects from therapy.

Learning Objectives

Upon completion of this activity, learners should be better able to:

• Describe guideline updates and newly approved medications that impact the treatment of patients with mCRC
• Identify biomarkers that can be used to help direct therapy for patients with mCRC
• Recognize, mitigate, and manage adverse events associated with standard and newer regimens for mCRC
• Implement an interprofessional approach to providing patient and caregiver counseling to reduce the risk of adverse events and complications and support optimal outcomes

 

Faculty

 

Accreditation Statement

In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designation

American Academy of CME, Inc (Academy) designates this enduring material for a maximum of 1.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NPs/Nurses: American Academy of CME, Inc. designates this educational activity for 1.5 ANCC contact hours (1.0 pharmacotherapeutic contact hours).

California
Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.5 contact hours. Other members of the care team will receive a certificate of participation.

This activity provides 1.5 ACPE contact hours (0.15 CEUs) of continuing education credit. Universal Activity Number JA4008191-0000-21-006-H04-P Application.

 

Disclosures of Conflicts of Interest

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.

Disclosure of relevant financial relationships are as follows:

Faculty Educators

Ravneet Bajwa, MD - no relevant financial relationships with ineligible companies to report.

Marcus Flores, PharmD, BCPS, BCOP
Clinical Pharmacist, Oncology
Hackensack Meridian Health

Marianne D. Gault, MSN, BS, RN, OCN - no relevant financial relationships with ineligible companies to report.

Planning Committee

John JD Juchniewicz, MCIS, CHCP, Natalie Kirkwood, RN, BSN, JD, Wendy Gloffke, PhD and Paul J. Miniter, MS, American Academy of CME - no relevant financial relationships with ineligible companies to report.

Independent Peer Reviewer

Val Adams, PharmD BCOP FCCP FHOPA
Associate Professor, Department of Pharmacy Practice and Science
College of Pharmacy
University of Kentucky

Dr. Adams has no relevant financial relationships with ineligible companies to report.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

1. Read the CME/CE information and faculty disclosures.
2. Participate in the online activity.
3. Complete the activity assessment (scoring at least 70%) and submit the evaluation form.

Certificates will be emailed to participants. Pharmacists will have their credit uploaded to CPE Monitor within 4 to 6 weeks.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This activity mentions tremelimumab, which has no trade name and is not FDA-approved but has been assigned an orphan drug designation by the FDA.

Disclaimer

The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

© 2022. This CE-certified activity is held as copyrighted © by American Academy of CME, Inc. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

Contact Information

For any questions, please contact: CEServices@academycme.org